Fayez Sarofim & CO Danaher Corp Transaction History

Fayez Sarofim & CO

$39.8 Billion
Q4 2024

A detailed history of Fayez Sarofim & CO transactions in Danaher Corp stock. As of the latest transaction made, Fayez Sarofim & CO holds 8,287 shares of DHR stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,287

Previous 8,237 0.61%

Holding current value

$1.55 Million

Previous $2.29 Million 16.91%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$226.16 - $274.52 $11,308 - $13,726	50 Added 0.61%	8,287 $1.9 Million
Q3 2024 Nov 14, 2024	SELL	$239.25 - $280.76 $17,943 - $21,057	-75 Reduced 0.9%	8,237 $2.29 Million
Q2 2024 Aug 14, 2024	BUY	$235.51 - $267.98 $82,428 - $93,793	350 Added 4.4%	8,312 $2.08 Million
Q1 2024 May 14, 2024	SELL	$224.58 - $256.19 $29,869 - $34,073	-133 Reduced 1.64%	7,962 $1.99 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $11,661 - $14,687	63 Added 0.78%	8,095 $1.87 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $47,082 - $53,649	-202 Reduced 2.45%	8,032 $1.99 Million
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $60,072 - $68,389	-267 Reduced 3.14%	8,234 $1.98 Million
Q1 2023 May 11, 2023	BUY	$239.75 - $277.0 $39,798 - $45,982	166 Added 1.99%	8,501 $2.14 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $74,118 - $452,220	300 Added 3.73%	8,335 $2.15 Million
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $354,005 - $447,392	1,493 Added 22.82%	8,035 $2.04 Million
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $57,113 - $70,098	-222 Reduced 3.28%	6,542 $1.92 Million
Q4 2021 Feb 11, 2022	BUY	$292.08 - $329.01 $208,545 - $234,913	714 Added 11.8%	6,764 $2.23 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $390,621 - $477,037	-1,435 Reduced 19.17%	6,050 $1.84 Million
Q2 2021 Aug 13, 2021	BUY	$225.08 - $271.69 $390,738 - $471,653	1,736 Added 30.2%	7,485 $2.01 Million
Q1 2021 May 13, 2021	BUY	$212.38 - $245.9 $43,537 - $50,409	205 Added 3.7%	5,749 $1.29 Million
Q4 2020 Feb 11, 2021	BUY	$212.5 - $245.46 $24,650 - $28,473	116 Added 2.14%	5,544 $1.23 Million
Q2 2020 Aug 11, 2020	BUY	$128.7 - $176.83 $29,858 - $41,024	232 Added 4.46%	5,428 $960,000
Q1 2020 May 12, 2020	BUY	$121.39 - $169.05 $81,209 - $113,094	669 Added 14.78%	5,196 $719,000
Q4 2019 Feb 14, 2020	BUY	$133.47 - $153.48 $20,020 - $23,022	150 Added 3.43%	4,527 $695,000
Q3 2019 Nov 13, 2019	BUY	$135.4 - $146.47 $20,310 - $21,970	150 Added 3.55%	4,377 $632,000
Q2 2019 Aug 09, 2019	SELL	$124.88 - $143.73 $44,457 - $51,167	-356 Reduced 7.77%	4,227 $604,000
Q4 2018 Feb 13, 2019	BUY	$94.85 - $109.54 $64,972 - $75,034	685 Added 17.57%	4,583 $473,000
Q2 2018 Aug 14, 2018	SELL	$96.1 - $103.24 $25,850 - $27,771	-269 Reduced 6.46%	3,898 $385,000
Q1 2018 May 10, 2018	BUY	$92.16 - $103.8 $18,892 - $21,279	205 Added 5.17%	4,167 $408,000
Q4 2017 Feb 13, 2018	BUY	$85.26 - $94.62 $22,934 - $25,452	269 Added 7.28%	3,962 $368,000
Q3 2017 Nov 08, 2017	BUY	$79.29 - $88.45 $292,817 - $326,645	3,693	3,693 $317,000

Others Institutions Holding DHR

# of Institutions

2,530

Shares Held

536M

Call Options Held

7.24M

Put Options Held

4.28M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $136B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account